ZYVERSA THERAPEUTICS, INC. Convertible Notes Payable, Current
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Convertible Notes Payable, Current of $1.20 million as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2026-05-13
- 2026-03-31: Convertible Notes Payable, Current $1.20M.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2026-03-31 | $1.20M 10-Q · filed 2026-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |